FDA Awards $2.25M Grant to Study Immunosuppresive Drug in High-Risk Patients
November 6, 2013
Transplant researchers at the University of Cincinnati have received a grant from the U.S. Food and Drug Administration to study the safety and efficacy of a generic immunosuppressive drug in high-risk transplant patients.